Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas

Sarah Cannon Research Institute at Mary Crowley is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at Mary Crowley has participated in 8 clinical trials with 7 currently active.

Therapeutic areas: Solid Tumors, KRAS Mutation, Advanced Solid Tumor, Non-small Cell Lung Cancer (NSCLC).

Sponsors: Boehringer Ingelheim, Gilead Sciences, Revolution Medicines, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at Mary Crowley?

Sarah Cannon Research Institute at Mary Crowley has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at Mary Crowley conducted?

Sarah Cannon Research Institute at Mary Crowley has 8 clinical trials on record, with 7 currently active. Their work covers Solid Tumors, KRAS Mutation, Advanced Solid Tumor, Non-small Cell Lung Cancer (NSCLC).

Is Sarah Cannon Research Institute at Mary Crowley accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute at Mary Crowley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at Mary Crowley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.